ICD therapy in coronary artery disease: A reappraisal in 2005

Herz

Volumn 30, Issue 2, 2005, Pages 82-86

  Grönefeld, Gerian ^b   Manegold, Johannes ^b   Israel, Carsten W ^b   Hohnloser, Stefan H ^a  

^a GOETHE UNIVERSITY   (Germany)

^b NONE

Author keywords

Coronary artery disease; Implantable cardioverter defibrillator; Sudden cardiac death

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

ANAMNESIS; AUTONOMIC DYSFUNCTION; CARDIAC RESYNCHRONIZATION THERAPY; CHRONIC DISEASE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; EVIDENCE BASED MEDICINE; HEART ATRIUM; HEART EJECTION FRACTION; HEART INFARCTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FAILURE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MEDICAL DECISION MAKING; PROPHYLAXIS; RELAPSE; REVIEW; SUDDEN DEATH;

COMORBIDITY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY DISEASE; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HUMANS; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 17744396463     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-005-2674-9     Document Type: Review

References (15)

1. Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980;303:322-4.
2. Connolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. Eur Heart J 2000;21:2071-8.
3. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmias. N Engl J Med 1996;335:1933-40.
4. Bigger JT, for the Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery. N Engl J Med 1997;337:1569-75.
5. Buxton AE, Lee KL, Fischer JD, et al., for the Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999;341:1882-90.
6. Moss AJ, Zarebra W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
7. Hohnloser SH, Kuck KH, Dorian P, et al. Randomized trial of prophylactic implantable cardioverter defibrillator after acute myocardial infarction. N Engl J Med 2004;351:2481-8.
8. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced heart failure. N Engl J Med 2004;350:2140-50.
9. Bardy GH, Mark DB, Poole JE, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
10. Wilber DJ, Zareba W, Hall WJ, et al. Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation 2004;109:1082-4.
11. Dorian P, Connolly S, Hohnloser S. Why don't ICDs decrease all-cause mortality after MI? Insights from the DINAMIT study. Circulation 2004;110:Suppl III:III-502.abstract.
12. Grönefeld G, Thorpe KE, Connolly SJ, et al. Competing risks for arrhythmic versus non-arrhythmic death in prophylactic ICD therapy early after myocardial infarction. Circulation 2004;110:Suppl III:III-502.abstract.
13. Gillis AM. Prophylactic implantable cardioverter-defibrillators after myocardial infarction - not for everyone. N Engl J Med 2004;351:2540-2.
14. Kadish A. Prophylacic defibrillator implantation - toward an evidence-based approach. N Engl J Med 2005;352:285-7.
15. The DAVID Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator. JAMA 2002;288:3115-23.